Shilpa provides integrated contract development and manufacturing solutions for pharmaceutical and biotechnology companies, supporting products from early development through commercial supply. Shilpa Biologicals offers end-to-end biologics capabilities spanning cell-line development, mammalian and microbial process development, drug substance manufacturing, formulation, analytical development, aseptic fill-finish, and packaging. The broader Shilpa network adds extensive capabilities in APIs, high-potency and oncology compounds, peptides, ADC payloads and linkers, specialty chemistry, sterile injectables, oral solids, oral thin films, and transdermal technologies. With experienced scientific teams, scalable manufacturing infrastructure, robust quality systems, and regulated-market experience, Shilpa provides flexible, integrated solutions designed to accelerate development, simplify technology transfer, strengthen supply continuity, and support clients from molecule to market.